2018 Pharma Choice Unbranded Bronze Winner NAVICOR and Celgene Corporation

NAVICOR

Celgene Corporation

Celgene “Chemosaurus”

Chemotherapy, a backbone of indolent non-Hodgkin’s lymphoma therapy for more than 50 years, has not evolved to match recent improved understanding of iNHL. Celgene is focused on therapies that allow cancer patients to thrive during treatment, virtually rendering chemotherapy extinct.

Agency Team:

Managing Director, Executive Creative Director: Marvin J. Bowe, III
VP, Creative Director: James A. Griffith II
ACD, Copy: Tom Ferrara
ACD, Art: Ana Ferreira
Sr. Art Director: John Catania
Sr. Art Director: Monica Ibarra
Design & Fabrication Firm: Creative Machines
CGI Artist: Taylor James

Ads

You May Also Like

PM360 2018 Innovative Product Edge Trial Assurance from Medidata

Edge Trial Assurance Medidata Erik Snider, Senior Director of Corporate Communications esnider@mdsol.com Nearly 50% ...

PM360 Magazine Announces Winners of 2019 Trailblazer Awards

Press Release For Immediate Release Contact: Andrew Matthius PM360 andrew.matthius@pm360online.com PM360 Magazine Announces Winners ...

PM360 2020 Innovative Startup wePool Inc.

wePool Inc. Guillermo Siman, CEO & Co-Founder gsiman@wepool.ai When it comes to managing pandemics, ...